Narrative review / 2015
Pomegranate polyphenols show anticancer mechanisms, but reported genotoxicity raises safety concerns.
This review analyzes the targets and mechanisms of pomegranate polyphenols in cancer prevention and therapy. Pomegranate displays antiproliferative, anti-invasive, and antimetastatic effects, induces apoptosis via Bcl-2 modulation, upregulates p21 and p27, downregulates the cyclin-cdk network, and blocks inflammatory pathways like NF-κB. Exploratory clinical trials showed a trend toward increasing prostate-specific antigen doubling time in prostate cancer patients. However, reported genotoxicity raises safety concerns, requiring accurate risk/benefit assessments before recommending therapeutic use.
- Study type
- Narrative review
- Who was studied
- Patients with prostate cancer (in exploratory clinical studies)
- What was measured
- Anticancer targets, mechanisms, and prostate-specific antigen doubling time
THE PAPER
Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy.
Turrini E, Ferruzzi L, Fimognari C. Oxid Med Cell Longev, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.